"10.1371_journal.pone.0044238","none","2012-09-07T00:00:00Z","Jes√∫s Rodr√≠guez-Ba√±o; Jes√∫s Mingorance; Natalia Fern√°ndez-Romero; Lara Serrano; Lorena L√≥pez-Cerero; Alvaro Pascual; the ESBL-REIPI group","Unidad Cl√≠nica de Enfermedades Infecciosas y Microbiolog√≠a, Hospital Universitario Virgen Macarena, Sevilla, Spain; Servicio de Microbiolog√≠a, Hospital Universitario La Paz - IdiPAZ, Madrid, Spain; Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain; Departamento de Microbiolog√≠a, Universidad de Sevilla, Sevilla, Spain","Conceived and designed the experiments: JRB JM AP. Performed the experiments: NFR LS LLC. Analyzed the data: JRB JM LLC AP. Contributed reagents/materials/analysis tools: JRB NFR LS LLC. Wrote the paper: JRB JM AP.","The authors have read the journals policy and have the following conflicts: J. Rodr√≠guez-Ba√±o has been a consultant for Wyeth, Merck, and Pfizer, has served as speaker for Wyeth, Merck, Pfizer, Astra-Zeneca and GlaxoSmithKline, and has received research support from Merck and Wyeth. J. Mingorance has received research support from Roche and Pfizer. A. Pascual has been a consultant for Merck and Pfizer, has served as speaker for Wyeth, Astra-Zeneca, Merck, and Pfizer and has received research support from Merck and Pfizer and Wyeth. All other authors had no conflict of interest. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","09","Jes√∫s Rodr√≠guez-Ba√±o","J√R√B√",7,TRUE,3,3,4,3,TRUE,TRUE,TRUE,1,"7",TRUE
